China

Stopwatch starts on reviews of GSK's long-acting asthma drug
Pharmaphorum
Tue, 01/28/25 - 10:19 am
GSK
asthma
depemokimab
Europe
China
Japan
The biopharma industry outlook on 2025: Uncertainty and change
BioPharma Dive
Sun, 01/26/25 - 04:16 pm
biotech
JPMHC 2025
China
regulatory
Donald Trump
GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thu, 01/23/25 - 11:40 am
Ab&B Bio-Tech
GSK
Merck
Pfizer
China
vaccines
IPOs
BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings
Fierce Biotech
Wed, 01/22/25 - 07:28 pm
China
Takeda
Bristol Myers Squibb
IPOs
Ascentage Pharma
Sichuan Biokin Pharmaceutical
Shanghai Bao
AstraZeneca overhauls management of its scandal-hit China division
Financial Times
Fri, 01/17/25 - 11:22 am
AstraZeneca
China
The Rise of China Innovation in the Time of Trump
BioSpace
Thu, 01/16/25 - 11:22 am
China
innovation
Donald Trump
trade
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
The ability to pivot will be ‘key’ as pharma’s tariff threat looms
Pharma Voice
Mon, 01/13/25 - 11:16 am
Donald Trump
tariffs
China
Mexico
drug pricing
CARsgen gets a win for CAR-T in solid tumors
Pharmaphorum
Fri, 01/3/25 - 09:55 am
CARsgen
solid tumors
satri-cel
CAR-T
China
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thu, 01/2/25 - 11:37 am
Roche
China
antibody-drug conjugates
small cell lung cancer
Trump tariffs and drug prices: 3 notes
Beckers Hospital Review
Thu, 01/2/25 - 11:16 am
Donald Trump
drug pricing
tarriffs
Mexico
Canada
China
2025 forecast: What can AstraZeneca's China probes teach other biopharma companies?
Fierce Pharma
Mon, 12/30/24 - 10:48 pm
AstraZeneca
China
Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision
Fierce Biotech
Fri, 12/20/24 - 11:26 am
Cytokinetics
Sanofi
China
aficamten
heart disease
Corxel Pharmaceuticals
Apollomics, after giving up on GlycoMimetics' leukemia therapy, posts drug's latest phase 3 fail
Fierce Biotech
Fri, 12/20/24 - 11:08 am
Apollomics
China
AML
uproleselan
Merck joins obesity pill race with up to $2B Hansoh deal
BioSpace
Wed, 12/18/24 - 11:18 am
Merck
obesity
China
Hansoh
GLP-1 agonists
Biosecure Act MIA from US defense bill in key win for China biopharma service providers
Fierce Pharma
Mon, 12/9/24 - 08:59 pm
legislation
China
Biosecure Act
Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready?
Pharma Voice
Fri, 12/6/24 - 09:09 am
Donald Trump
tariffs
China
generics
GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
Fierce Pharma
Thu, 12/5/24 - 11:39 am
GSK
China
Zhifei
Shingrix
GSK goes East again, snagging option on preclinical DualityBio ADC for $30M
Fierce Biotech
Wed, 12/4/24 - 10:58 am
GSK
China
DualityBio
antibody-drug conjugates
Sanofi announces its biggest China investment deal amid China-EU trade tensions
MSN/Reuters
Mon, 12/2/24 - 10:51 am
Sanofi
China
insulin
drug manufacturing

Pages